PSA to Prostate Imaging Prostate Cancer MRI Physimed Health Group

PSA to Prostate Imaging Prostate Cancer MRI Physimed Health Group

21 Prostate Cancer MRI Accurate Diagnosis and Treatment Physimed Health Group PSA to Prostate Imaging for patients and curious doctors Samuel Aron...

432KB Sizes 0 Downloads 3 Views

Recommend Documents

AccelerAting Discovery - Prostate Cancer Foundation
Lawrence J. and Joyce Stupski. Tarnopol Family Foundation .... Laurence and Karen Mandelbaum. Bernard Marcus ... Henry a

Prostate Cancer 2017: The Coming Sea-Change of Prostate Cancer
Aug 17, 2017 - Prostate Cancer 2017: The Coming Sea-Change of Prostate Cancer Care | Simms/Mann-UCLA Center for Integrat

Prostate cancer Screening - Human Health Campus
Nuclear Medicine, University Hospital Zurich, Switzerland. (A) MRI axial T2 weighted image showing indeterimined 5 mm ly

Thank you - Prostate Cancer UK
The Milly Apthorp Charitable Trust. - The Open Agency. - The Rangers Charity Foundation. - The Simon Gibson Charitable T

banana bread - Prostate Cancer UK
Angela Hartnett MBE. BANANA BREAD. Makes one loaf (12 slices). Ingredients. • 100g Sultanas. • 75ml rum. • 4 Small

Unproven Therapies in Prostate Cancer
Theranos was performing tests on patients without having published peer-reviewed research – a cardinal science – and

strawberry shortcakes - Prostate Cancer UK
STRAWBERRY SHORTCAKES. Makes 8. Ingredients. For the Shortcakes: • 325g plain flour. • ½ tsp salt. • 1 tbsp bakin

Likelihood of Prostate Cancer Based on Prostate-Specific Antigen
Ullrich G. Mueller-Lisse, Ulrike L. Mueller-Lisse, Steffen Haller, Peter Schneede,. Juergen E. Scheidler, Nicolaus Schme

Castrated Cancer Patient - Cincinnati Prostate Cancer Information Group
Ehrsson, H. H., Spence, C., & Passingham, R. E. (2004). That's my hand! Activity ... Ehrsson, H. H., Holmes, N. P., & Pa

Prostate Cancer Foundation Releases Its First Annual Report to the
Chairman. Prostate Cancer Foundation. Merv Adelson. Chairman. East West Venture Group. Jim Allchin. Group Vice President

21

Prostate Cancer MRI

Accurate Diagnosis and Treatment

Physimed Health Group

PSA to Prostate Imaging for patients and curious doctors Samuel Aronson, M.D. Albert Benhaim M.D. Franck Bladou, M.D. Armen Aprikian, M.D. & Marc Emberton, M.D. Forewords

Physimed Health Group Individual Evaluation Objectives: • Determining a man’s risk of developing prostate cancer as a serious illness • Diagnose prostate cancer in men at high risk • Monitor men at high risk, on active surveillance with cancer or for residual or recurrent cancer after treatment • MRI local staging of prostate cancer

Risk Assessment (includes some of these criteria) Age, life expectancy, major illnesses, family-genetic history, race, chemicalmedication exposures, previous (UTI, MRI, biopsy, pelvic surgery, radiation), predictor tables, urology exam, rectal exam, urinalysis-culture, PSA , PSA progression, biomarkers, testosterone, renal function, TRUS-PSA density

Prostate MRI • New remarkable ability to detail image of prostate anatomy, physiology and microvasculature. • 94 % accurate in diagnosing prostate cancer • Image based diagnosis, treatment and monitoring of prostate cancer which was inaccurate before MRI • Time consuming for Radiologist and Urologist to learn, interpret and to clinically implement (Learn more, pamphlets 6 & 7)

MRI Essentials • Experienced Technician, Radiologist and Urologist • MRI Request and consent forms • Patient instructions • Precise standardized acquisition of the MR Images and reporting • Ultrasound/MRI images fusion for targeted biopsy • Multidisciplinary case review

Ultrasound/MRI Fusion Targeted Biopsy

external anatomy Provides visualization for needle placement internal structures Locates, targets the suspicious cancer nodule(s) • Requires clear, clinically useful MRI reports and DVDs • TRUS/MRI knowledgeable Urologist • Pathologists to provide the proof of the presence of cancer

Our Prostate Cancer Diagnostic Team Radiologists

Provide and interpret the MRI to identify the undiagnosed, residual or recurrent cancers. Drs. G. Artho, C. Reinhold, J. Taylor

Urologist

Use the MRI to select which men to biopsy, where to biopsy for treatment decisions and monitoring. Drs. M. Anidjar, S. Aronson, W. Kassouf

Pathologists

Provide the tissue proof of the presence of cancer Dr. L. Begin

T2w

Normal Prostate MRI

DCE

Prostate MRI

ADC

DWI

With a thorough Prostate Cancer Risk Assessment MRI may not be needed With a MRI Biopsy may not be needed When biopsy is required TRUS/MRI fusion targeted is very accurate (Learn more Pamphlet 3) SAMUEL ARONSON, M.D.

Assistant Professor of Urology, McGill University

ALBERT BENHAIM, M.D.

Jewish General Hospital Groupe Santé Physimed 3755, Côte Ste-Catherine Rd, E-959 6363, Transcanadienne, suite 121 Montreal (Quebec) H3T 1E2 Saint-Laurent (Quebec) H4T 1Z9 Phone: 514 340-7558 Phone: 514 747-8888 Fax: 514 340-7559 Fax: 514 747-8188 Design by Annie Desjardins Sponsored by Groupe Santé Physimed

www.pcamri.com